Pharma Tech Outlook’s Post

A fantastic keynote panel discussing how to shape the future of pharma through sustainable medical innovation and equitable access is underway. A crucial topic with insightful learnings during the current IRA era. Excellent insights from Eric Peacock, Chris Leibman, Bhavesh Ashar and Charlotte Bastiaanse on how to make sure no patient ever gets left behind. #REpharmaUSA

Pharma companies must find ways to get closer to the real-life experiences of their patients. David Laros explains how companies can map the patient's ecosystem of care, turn data into action and drive engagement through patient- and HCP-focused campaigns. Read more here: https://lnkd.in/gNCBJ3uk

Join Slalomer Kimberly Rojek at Pharma USA's "Are you really listening to your patients?" panel for a discussion on the evolution of patient engagement and finding hidden insights in patient data sets to extract true value. Let me know if I’ll see you there! #REpharmaUSA #ImWithSlalom

Join Slalomer Kimberly Rojek at Pharma USA's "Are you really listening to your patients?" panel for a discussion on the evolution of patient engagement and finding hidden insights in patient data sets to extract true value. Let me know if I’ll see you there! #REpharmaUSA #ImWithSlalom

🎬 Revolutionizing Pharma: Uncover the Patient Engagement Framework, a game-changer in patient-centric strategies. From pandemic challenges to a 360-degree view, explore the benefits and join the shift towards prioritizing patient well-being. Visit our web: bioexplore.org and explore the framework developed by IQVIA at https://lnkd.in/ePAjWfq2. #PatientCentricity #HealthcareRevolution #PharmaInnovation #PatientEngagementFramework #HealthcareFuture #InclusiveStrategies #StrategicDecisionMaking #WellbeingPriority #ClinicalExcellence #HealthcareEvolution #PatientAdvocacy #DigitalHealth #DecentralizedTrials #PharmaceuticalIndustry #LatinAmericanHealthcare

Register to learn and engage with this panel of experts who will share insights to help you create trials that not only meet regulatory and scientific standards, but also align with the needs and experiences of patients, placing them at the heart of every decision.

Join Slalomer Kimberly Rojek at Pharma USA's "Are you really listening to your patients?" panel for a discussion on the evolution of patient engagement and finding hidden insights in patient data sets to extract true value. Let me know if I’ll see you there! #REpharmaUSA #ImWithSlalom

Calling all patient engagement proponents, this webinar is for you and your teams!

Scaling is crucial in every industry, but the stakes are higher in clinical trials. By scaling effectively, we can ensure that more patients have access to innovative treatments and therapies, leading to improved health outcomes and quality of life. But where do you start? How can organizations navigate the complexities of scaling in clinical trials? Join me on March 20th, 11a EST/ 3p GMT as Nicole DuPont Latimer, CEO of Medrio, sits down with Khone Saysana and Walter S. of Roche to explore these questions and more. They will cover: 📈 The importance of adhering to standardized practices and protocols to enhance reliability, consistency, and successful outcomes. 🔬Strategies for achieving efficiencies through strategic scaling in drug development. 💼Insights into the future of clinical trials and how scaling will shape the landscape. Don't miss the opportunity to gain insights from industry leaders and experts. Click the link in my comments to register now and secure your spot! #ClinicalTrials #Scaling #Innovation

The #1 objective of most pharma commercial organizations is a successful launch as the first 6 months are critical to long term viability. During this critical period, companies have the opportunity to outperform established competitors through agile, intelligent customer engagement. One of the biggest oversights during this period is a strategically minded Patient Engagement and Support (PES) program. Today's patients have more agency and strong opinions than ever before, influencing the treatments they receive and their HCP's prescribing patters. Read more in IQVIA's white paper below! #LaunchExcellence #Innovation #Pharma #BioPharma #Commercial #Patients #Data #IQVIA Eliza Silvester Matthew Smith Matt Doyle Nick Mageras Carmen Sivakumaren, PhD Abir Yamak, Ph.D. Eric E. Bayir, MSc, MBA, Gonzalo Lemus Greg Plante Elyse Muñoz, PhD Leah Magid Herbert Valerie Eng Erin Gerardo Annie Curti Rounak Baid Luke Greenwalt Patrick Dunn Shirish Gupta Michael Loconzolo Vincent Ciro Ankur Chopra Kelley Coalier, MS, MBA Indraneel Mukherjee, Aakansha Nangarlia, PhD Yash Dave, Bill Jensen Daniel Feld, MBA, MPH Pam Ramali Chris Mathura Gloria Brownell Aziz Mallik Rachel Cunningham Brian Hannah Michael Wojeck Brian Lovinguth Angela Richardson Jara Soltero Angela Donato James Noll https://lnkd.in/edTsvPzN